GV vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 25, 2026

GV

45.2
AI Score
VS
UTI Wins

UTI

57.2
AI Score

Investment Advisor Scores

GV

45score
Recommendation
HOLD

UTI

57score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GV UTI Winner
Revenue 5.04M 835.62M UTI
Net Income -15.84M 63.02M UTI
Net Margin -314.1% 7.5% UTI
Operating Income -3.47M 83.47M UTI
ROE -309.6% 19.2% UTI
ROA -24.9% 7.6% UTI
Total Assets 63.63M 826.14M UTI
Cash 334,910 127.36M UTI
Debt/Equity 0.10 0.27 GV
Current Ratio 0.07 1.07 UTI

Relative Price Performance (Last 90 Days)

GV 1M: -31.7% · 3M: -30.7% UTI 1M: -15.4% · 3M: +10.7%

Current Technical Phase

GV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.8%), weak momentum, RSI 35

RSI (14): 34.8 · Price: $0.14

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.6 · Price: $40.83

Fundamentals Snapshot

Metric GV UTI
Market Cap
Forward P/E 0.0 46.2
Trailing P/E 54.1
Revenue (TTM)
Revenue Growth -0.6% 0.1%
Gross Margin 0.3% 0.6%
Operating Margin -1.9% 0.0%
EPS -4.09 0.74
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.